Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tirzepatide for Individuals With Comorbid Obesity and Methamphetamine Use Disorder

NCT06745128 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT06745128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06745128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tirzepatide for Individuals With Comorbid Obesity and Methamphetamine Use Disorder
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 3, 2025
Completion date
February 12, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorder, obesity